NEW DELHI, March 30 (Reuters) - India's Ranbaxy Laboratories (RANB.BO) said on Monday it had received the U.S. Food and Drug Administration's approval to make and sell topirimate tablets, used for the treatment of seizures.
The tablet is a generic version of epilepsy drug Topamax, owned by Ortho-McNeil Pharmaceutical Inc, a unit of Johnson & Johnson (JNJ.N). (Reporting by Devidutta Tripathy)
WASHINGTON (Reuters) - Senate Democrats cleared the last 60-vote hurdle on President Barack Obama's healthcare overhaul on Wednesday, virtually ensuring final passage of its version of the biggest health policy changes in four decades.
Nukes may not be the only ticking clock in Iran. The reformist movement is swelling and "it is going to get very violent." Full Article
It might not shake up the industry just yet, but China's interest in Volvo and Saab is the start of something big in global autos. Commentary | Video
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
